🟢 HCW Biologics is trading 9.4% up in pre-market

HCW Biologics is trading at $1.28, up 9.40%, in pre-market; the immediate catalyst is unclear.

• No confirmed company-specific catalyst was identified for the October 15 pre-market rise.
• The latest company release located was October 9 and concerned progress toward an IND application for its T-cell engager candidate; it does not establish a reason for the move.
• The Nasdaq was down, offering no clear explanation for the stock’s rise.